Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Gradual Dose Reduction vs Abrupt Withdrawal for Hyperalgesia
NCT01702389Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in hyperalgesia, sponsored by Oslo University Hospital. Started Oct 2012; status: completed.
02
Drugs
remifentanil
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT01702389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702389.